1 Min Read
Sept 4 (Reuters) - Cosmo Pharmaceuticals SA :
* FDA approves Cosmo’s submucosal injectable composition SIC 8000 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.